BioSpace News Archive

InMode Ltd. today announced a two-for-one (2:1) share split of the Company’s ordinary shares, with a record date of September 27, 2021 (the “Record Date”).

BIOREM Inc. today announced that at the special meeting of shareholders held on September 16, 2021 the shareholders approved the purchase for cancellation of 23,434,121 common shares of the Company from TPFG Environment Investment Limited

Celsion Corporation and Hainan Poly Pharm Co. Ltd. announced an amendment to their existing contract manufacturing agreement to include development work for Celsion’s investigational DNA-based COVID-19 vaccine.

Avalo Therapeutics, Inc. announced today the closing of the previously announced underwritten offering of common stock, including the purchase of 1,808,878 additional shares pursuant to the exercise by the underwriters of their option to purchase additional shares at a public offering price of $2.20 per share.

The 2020 conference attracted close to 900 attendees from around the world. Attendees included: academic and industry scientists, business development and licensing professionals, venture capitalists and other investors.

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, will report financial results for the fiscal year ended June 30, 2021, on Friday, September 24, 2021.

Auto-injector is a medical device designed to deliver a dose of a particular drug. Disposable and reusable auto-injectors are the two types of auto-injector.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others.

The diaphragm pacing therapy system market is expected to observe a positive growth trajectory during the forecast period of 2020-2030.

Presently, a number of health problems related to stomach such as ulcer, liver, intestinal pain and cancer, and skin related problems are rising rapidly.